This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,516 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A high-profile rift between two longtime mentors-turned-critics shines a light on how money, branding, and risk manag...
Investors debate timing as IREN plans a bold AI expansion after a major capital raise. This guide breaks down the pla...
When a juggernaut like Fortnite cools its engagement, the ripple effect hits the entire company. This piece digs into...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
The crypto market has cooled from its peaks, but two names consistently draw attention: Ethereum and Solana. This gui...
A late-night incident went viral for all the wrong reasons, and the real price wasn’t just fear or headlines. This pi...
When a tech giant like Nvidia makes a bold $2.2 billion investment in a fast-growing AI company, it signals more than...
A blue-chip industrial like Caterpillar may seem unlikely in an AI story. Yet the demand for data-center sites and th...
Investors are keen on LENZ as the company reports Q1 2026 earnings. This in-depth look breaks down the key numbers, w...
With rates steady and mobility rising, financial advisors contend that the decision to rent or buy depends on your li...
Lane Generational just disclosed a sizeable stake in Evolv Technologies, signaling potential interest from big invest...